These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20684428)

  • 1. [Adherence to long-term medication: the particular case of the adjuvant endocrine therapy for breast cancer].
    Bleret V; Collignon J; Coucke P; Cusumano P; Desreux J; Herman P; Jerusalem G; Maweja S; Remacle N; Rorive A; Lifrange E
    Rev Med Liege; 2010; 65(5-6):405-8. PubMed ID: 20684428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to long-term adjuvant hormonal therapy for breast cancer.
    Gotay C; Dunn J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-15. PubMed ID: 22098287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
    Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
    Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
    Ekinci E; Nathoo S; Korattyil T; Vadhariya A; Zaghloul HA; Niravath PA; Abughosh SM; Trivedi MV
    J Cancer Surviv; 2018 Jun; 12(3):348-356. PubMed ID: 29396760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to adjuvant endocrine therapy in women with breast cancer.
    Danilak M; Chambers CR
    J Oncol Pharm Pract; 2013 Jun; 19(2):105-10. PubMed ID: 22895656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to endocrine therapy for breast cancer.
    Chlebowski RT; Geller ML
    Oncology; 2006; 71(1-2):1-9. PubMed ID: 17344666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer.
    Ejlertsen B; Jensen MB; Mouridsen HT;
    Acta Oncol; 2014 Feb; 53(2):174-85. PubMed ID: 24219541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence rates and correlates in long-term hormonal therapy.
    Dunn J; Gotay C
    Vitam Horm; 2013; 93():353-75. PubMed ID: 23810015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance and persistence of endocrine adjuvant breast cancer therapy.
    Güth U; Myrick ME; Kilic N; Eppenberger-Castori S; Schmid SM
    Breast Cancer Res Treat; 2012 Jan; 131(2):491-9. PubMed ID: 21976056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
    Lundgren C; Lindman H; Rolander B; Ekholm M
    Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
    Tinari N; Fanizza C; Romero M; Gambale E; Moscetti L; Vaccaro A; Seminara P; Longo F; Gori S; Vici P; Gamucci T; Mauri M; Laudadio L; Nuzzo A; Fabbri MA; Fattoruso SI; Mazzilli L; Grassadonia A; Cianchetti E; Natoli C
    Clin Breast Cancer; 2015 Apr; 15(2):e131-7. PubMed ID: 25454738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant endocrine therapy for breast cancer: how long is long enough?
    Jankowitz RC; Davidson NE
    Oncology (Williston Park); 2013 Dec; 27(12):1210-6, 1224. PubMed ID: 24624537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant endocrine therapy for breast cancer.
    Rao RD; Cobleigh MA
    Oncology (Williston Park); 2012 Jun; 26(6):541-7, 550, 552 passim. PubMed ID: 22870539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.
    Quinn EM; Fleming C; O'Sullivan MJ
    Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.
    Neven P; Markopoulos C; Tanner M; Marty M; Kreienberg R; Atkins L; Franquet A; Gnant M; Neciosup S; Tesarova P; Barni S; Deschamp V
    Breast; 2014 Aug; 23(4):393-9. PubMed ID: 24675394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
    Murphy CC; Bartholomew LK; Carpentier MY; Bluethmann SM; Vernon SW
    Breast Cancer Res Treat; 2012 Jul; 134(2):459-78. PubMed ID: 22689091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of adjuvant endocrine breast cancer therapy in the oldest old.
    Güth U; Myrick ME; Kandler C; Vetter M
    Breast; 2013 Oct; 22(5):863-8. PubMed ID: 23541734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to endocrine therapy of breast cancer: recent advances and tomorrow's challenges.
    Geisler J; Lønning PE
    Clin Breast Cancer; 2001 Jan; 1(4):297-308; discussion 309. PubMed ID: 11899352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.
    Xu H; Jin F; Zhang XJ; Wang DQ; Yu SF; Wang AP
    Cancer Med; 2020 Jun; 9(11):3703-3713. PubMed ID: 32237070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.